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ABSTRACT
Objectives: To examine which interventions
healthcare professionals use to support patients with
taking medicines and their perceptions about the
effectiveness of those actions.
Design: Cross-sectional multinational study.
Setting: Online survey in Austria, Belgium, England,
France, Germany, Hungary, The Netherlands, Poland,
Portugal and Switzerland.
Participants: A total of 3196 healthcare professionals
comprising doctors (855), nurses (1047) and
pharmacists (1294) currently registered and practising
in primary care and community settings.
Main outcome measures: Primary outcome:
Responses to the question ‘I ask patients if they have
missed any doses of their medication’ for each
profession and in each country.
Secondary outcome: Responses to 50 items
concerning healthcare professional behaviour to
support patients with medication-taking for each
profession and in each country.
Results: Approximately half of the healthcare
professionals in the survey ask patients with long-term
conditions whether they have missed any doses of
their medication on a regular basis. Pharmacists
persistently report that they intervene less than the
other two professions to support patients with
medicines. No country effects were found for the
primary outcome.
Conclusions: Healthcare professionals in Europe are
limited in the extent to which they intervene to assist
patients having long-term conditions with medication
adherence. This represents a missed opportunity to
support people with prescribed treatment. These
conclusions are based on the largest international
survey to date of healthcare professionals’
management of medication adherence.
INTRODUCTION
The majority of research on medication
adherence has focused on understanding
and changing the patient, particularly their
beliefs about medicines,1 2 rather than
understanding and changing the context in
which care and treatment is provided.
Systematic reviews show that interventions—
designed to improve adherence for chronic
health problems—such as patient education,
psychological therapy, simpliﬁed dosing and
family intervention, tend to be complex in
nature and low in effectiveness.3
Some research has examined the role of
healthcare professionals in patients’ adher-
ence, although this has focused predomin-
antly on physicians’ communication and
characteristics.4 5 Despite evidence from
this research suggesting that healthcare
professionals can signiﬁcantly affect
patients’ adherence to medication, the
beliefs, perceptions and practices of health-
care professionals have received relatively
little attention. The effectiveness of
adherence-enhancing interventions needs
to be examined in a broader context that
encompasses the role of healthcare profes-
sionals. Healthcare professionals have an
Strengths and limitations of this study
▪ This study is novel, with a large, multinational
European sample of three healthcare professions
(doctors, nurses and pharmacists), and is the
largest survey to date of the behaviours under-
taken in routine clinical practice in primary care
to support patients in the use of their medicines.
▪ We provide evidence that there is scope for
patients to be better supported with medicines
use and the potential value of education and
training for healthcare professionals to achieve
this.
▪ There is a risk of self-selection bias and risks
inherent in the self-reporting of behaviour.
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important role to play in providing support to patients
in order to ensure that if patients agree to take medi-
cines, they do so in a safe, effective and cost-effective
way. However, evidence suggests that healthcare pro-
fessionals may not be fulﬁlling this role, in part as they
tend to underestimate the incidence of non-
adherence in their patients.6 Few physicians receive
formal training in patient adherence, though the
assessment of patient adherence and the use of
adherence-enhancing interventions is signiﬁcantly
greater among those who do receive formal training.7
Improving the skills of healthcare professionals in
properly assessing the risk of non-adherence in
patients and delivering interventions aimed at redu-
cing non-adherence, may therefore lead to more
effective support for patients taking prescribed
medicines.
In order to gain a more complete understanding of
the range of potentially adherence-enhancing interven-
tions delivered by healthcare professionals in routine
daily practice and their perceived effectiveness, we con-
ducted a survey on the adherence management of
doctors, nurses and pharmacists across 10 European
countries.
METHODS
Design
The paper focuses on the self-reported behaviours of
primary care healthcare professionals in 10 European
countries to support patients with taking prescribed
medicines for long-term conditions, using a cross-
sectional online survey. The protocol for this study has
been published elsewhere.8
Setting and participants
Participants were healthcare professionals who were cur-
rently registered to practice and employed as medical
doctors, nurses or pharmacists, working with adults in
primary or community care in 1 of 10 European coun-
tries: Austria, Belgium, England, France, Germany,
Hungary, The Netherlands, Poland, Portugal and
Switzerland.
Sample size was based on the estimation of the propor-
tion of those participants who answer ‘never’ to the
primary outcome: ‘I ask patients if they have missed any
doses of their medication’ in each country. Following
Cochran,9 a sample size of 384 health care professionals
in each country (128 people for each professional group)
was required to enable estimation with 95% conﬁdence.
Procedure
A mixed-method approach was used to recruit partici-
pants in each country, adapted as necessary dependent
on the availability and accessibility of national registers
of healthcare professionals. Recruitment was via profes-
sional bodies and associations when registers were not
available.
The online questionnaire was administered using
SurveyMonkey.com (http://www.SurveyMonkey.com).
No personal information (such as names, addresses and
professional licence numbers) were collected from parti-
cipants and no IP addresses were stored or downloaded.
Ethics approval was provided by the NRES Committee
North West Liverpool East (REC Reference 11/NW/
0156) for England and used as the basis for ethics and
research governance in the other European countries,
adapted as necessary to meet national ethical
requirements.
Measures
It was not possible to identify any validated scales of
healthcare professional behaviour in this domain, but
two unvalidated, published questionnaires have been
used to measure adherence intervention behaviours and
their perceived effectiveness among hospital-based
doctors,4 and cardiovascular and transplantation
nurses.10 Our questionnaire was informed by these previ-
ous studies, recommendations for clinical practice from
published adherence guidelines,1 10–12 and was dis-
cussed, reviewed and piloted by the research team. The
questionnaire is available from the corresponding
author.
Fifty questions concerning adherence-enhancing inter-
ventions were presented in ﬁve subsections: assessment
of adherence and its risk factors (example item, ‘I use
electronic monitoring devices to assess patients’ level of
adherence’); providing information for carers and
patients (eg, ‘I check that patients understand the infor-
mation that I have given them’); talking with patients
about their medications (eg, ‘I ask patients what level of
involvement they would like in making decisions about
their treatment’); practical strategies to make medication
taking easier (eg, ‘I help patients to tailor their medica-
tion regimen to their own lifestyle’); and involving
others and services to support adherence (eg, ‘I refer
patients to peer mentor programmes to support medica-
tion adherence’). Following Berben et al,13 respondents
were asked how often they used each intervention (from
‘never’ to ‘all the time’ with the response category ‘not
applicable’ available to participants who did not use the
intervention mentioned) and how effective they think
that intervention is (‘not at all’ ‘somewhat’, ‘extremely’,
with the option of responding ‘don’t know’).
The survey was translated into the appropriate lan-
guages using accredited translators who were native
speakers of the target languages and ﬂuent in English.
Translations were checked for compatibility with the ori-
ginal version in a process of back translation, performed
by persons who were native English speakers and ﬂuent
in each target language. For each language, a third indi-
vidual acted as a reviewer, and highlighted any discrep-
ancies between the forward and back translations, which
were resolved by discussion with the translators.
Translations were coordinated by one project partner to
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ensure consistency. Piloting in each country enabled
identiﬁcation of any semantic inconsistencies.
Primary and secondary outcomes
The primary outcome was responses to the question ‘I
ask patients if they have missed any doses of their medi-
cation’ for each profession and in each country.
Secondary outcomes were responses to the 50 items
concerning healthcare professional behaviour to
support patients with medication-taking for each profes-
sion and in each country.
Statistical analysis
Quantitative analyses for the primary outcome were per-
formed using MLwiN (http://www.cmm.bristol.ac.uk/
MLwiN/) for both, binary and ordered categories.
Responses to the primary outcome were categorised to
form a binary variable coded as 1 if the intervention had
never been used and 0 for all other response options.
Participants who indicated that the item was not applic-
able to their particular role were excluded from the ana-
lysis. Post hoc we found that the frequency of the
primary outcome (never asking patients if they had
missed any doses of their medication) produced a rela-
tively small number of responses; consequently, a further
analysis was carried out using the binary outcome where
patients were asked frequently or all the time about
missed doses.
Analysis of primary outcome
We evaluated the effect on the primary outcome of
groups of predictor variables. The group of demo-
graphic variables comprised gender and age of respon-
dents, while professional practice encompassed number
of years registered as a qualiﬁed healthcare professional,
the average amount of time spent talking with patients
about their use of medications, any pre-registration or
post-registration training in medication adherence man-
agement and support, and the use of practitioner guide-
lines to assist with the management of patients’
adherence. Multiple logistic regression was used, taking
into account the hierarchical nature of the data, and the
results are presented as ORs and their 95% CIs. Where
there were ordinal responses, the lowest was taken as the
comparator value and ORs are presented for the binary
responses for categorical variables, for instance the use
of practitioner guidelines to assist with the management
of patient adherence. Where there are variables mea-
sured over a more extensive range, such as age, then
ORs represent the change per unit (per year for age).
Where there appeared to be a trend in the predictors,
this was tested. Logistic regressions were applied with
random intercepts, which were allowed to vary at both
the country and profession level, and ﬁxed effects for all
variables within the three groups. A preliminary analysis
where the intercept was allowed to vary at the country
level and with a profession ﬁxed effect is also given. In
practice, in most cases the country effects were not
signiﬁcant and models were reﬁtted with only profession
random effects.
Structure of analysis
Two sets of between-participants analysis of variance
(ANOVA) were conducted on the data on healthcare
professionals’ use of adherence-enhancing interventions.
First, a series of ANOVAs are reported for the main
effects of profession and nation on healthcare profes-
sionals’ total ratings for each of the ﬁve categories of
adherence-enhancing interventions and perceived bar-
riers to implementing interventions for adherence. Data
for all professions and all participating nations were
included in these analyses. To enable testing for poten-
tial interactions between profession and nation for each
of the outcome variables, a second series of ANOVAs is
reported. As data were not collected from nurses in
France and Germany, the data from these nations were
excluded in this second series of analyses. The sample
sizes for both sets of analysis were considered large
enough so that normality based tests were appropriate,
however, inferences were checked using the non-
parametric Kruskall-Wallis test.
ANOVA: main effects
All analyses were carried out using NCSS 2007
(V.07.1.19, J Hintze (2009), Kaysville, Utah, USA).
Initially, a series of 3×10 between-participants ANOVAs
using the General Linear Model (GLM) procedures was
conducted to examine the main effects of profession
and nation on total scores for healthcare professionals’
use of adherence-enhancing interventions for each cat-
egory of intervention. Corrections for multiple testing
were carried out within each variable.
ANOVA: interaction effects
As data were not collected from nurses in France or
Germany, a further series of ANOVAs was necessary to
explore the effects of interactions between profession
and nation on total ratings for healthcare professionals’
use of adherence-enhancing interventions.
RESULTS
A total of 4967 healthcare professionals started the
survey; 3196 reported their profession and were
included in the analysis. Demographic information for
the sample is presented in table 1. Means and SDs for
speciﬁc adherence-enhancing interventions by profes-
sion and by nation can be found in online
supplementary tables 1–4.
Primary outcome
For both versions of the primary outcome, the ORs and
their CIs suggest that pharmacists are approximately 2.8
times more likely than doctors to have a never response
to the question ‘I ask patients if they have missed any
doses of their medication’, and the doctors and nurses
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Table 1 Demographic data
Sample size
Total N=3196; Austria=698; Belgium=289; England=318; France=133; Germany=303; Hungary=322; The
Netherlands=91; Poland=571; Portugal=53; Switzerland=418; doctors=855; pharmacists=1294; nurses=1047
Age (mean and SD) 44.77 (10.96)
Gender Male=1102; female=2069
Years since qualifying (frequency
distribution)
Less than
1 year
N=86
1–5 years
N=354
6–10 years
N=374
11–
15 years
N=439
Over 15 years
N=1935
Type of healthcare setting (frequency
distribution)
Community
hospital
N=385
Family
medication/
general practice
N=820
Specialist
community
service
N=104
Care/
nursing
home
N=155
Community
pharmacy/
dispensary
N=1175
Community
nursing team
N=154
Polyclinic
N=45
Other
N=308
Type of healthcare organisation (frequency
distribution)
Privately
funded
N=1127
State funded
N=1050
Insurance/sick
fund funded
N=531
Mixed
funded
N=44
Other funding
N=302
Length of time spent talking to patients
about their use of medications (frequency
distribution)
No time at all
N=34
Less than 1 min
N=158
1–5 min
N=1715
6–10 min
N=801
11–15 min
N=226
More than
15 min
N=199
Pre-registration training in medication
adherence management and support
(frequency distribution)
Yes
N=296
No
N=1780
Post-registration training in medication
adherence management and support
(frequency distribution)
Yes
N=684
No
N=1392
Any training in medication adherence
management and support (frequency
distribution)
Yes
N=803
No
N=1268
Use of practitioner guidelines to assist with
management of patient adherence to
medication (frequency distribution)
Yes
N=468
No
N=1586
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were not signiﬁcantly different from each other.
Pharmacists are also approximately 4.6 times less likely
to ask patients frequently or all the time if they have
missed any doses of their medication. The results for
both outcomes are presented in tables 2 and 3.
The country random effect was found to be non-
signiﬁcant. Both age and gender were found to have
non-signiﬁcant effects with ORs near 1 and 95% CIs
containing 1. Length of time registered as a qualiﬁed
healthcare professional appears to have a positive effect
on both outcomes. This is more marked for the never
asked outcome; however, there is no discernible trend
over the categories. For length of time spent talking with
patients about their use of medications, there is a signiﬁ-
cant trend downwards (OR=0.524 per unit change, 95%
CI 0.36 to 0.727) and upwards (OR=1.42/unit change,
95% CI 1.27 to 1.57). Training, which was a binary vari-
able reﬂecting any pre-registration and/or post-
registration training in medication adherence manage-
ment and support, has a nearly signiﬁcant effect for the
never category, where those who reported training were
approximately 60% less likely to never ask patients about
missed doses. For the frequently/always outcome, train-
ing predicts an approximately 42% increase in this
outcome. The use of practitioner guidelines to assist
with the management of patient adherence to medica-
tion does not reach signiﬁcance but point estimates of
the ORs indicate similar positive effects for both
outcomes.
Internal reliability of measures
Cronbach’s αs indicated that the items assessing ‘provid-
ing information for patients/carers’ (α=0.80), ‘talking
with patients about their medications’ (α=0.87), ‘prac-
tical strategies to make medication taking easier’
(α=0.83), and ‘involving others and other services to
Table 2 Summary of multiple logistic regression for never
asking patients about missed doses as the dependent
variable
Variable OR 95% CI
Profession*
Doctor 1.00
Pharmacist 2.80 1.71 to 4.58
Nurse 0.92 0.50 to 1.69
Demographics‡
Gender
Male 1.00
Female 0.91 0.59 to 1.43
Age
Per year 1.02 0.84 to 1.24
Professional practice‡
Number of years registered as a qualified healthcare
professional
Less than 1 year 1.00
1–5 years 0.22 0.07 to 0.71
6–10 years 0.40 0.14 to 1.17
11–15 years 0.31 0.10 to 0.92
Over 15 years 0.22 0.08 to 0.60
Time spent talking with patients about their use of
medications
No time at all 1.00
Less than 1 min 0.63 0.13 to 3.19
1–5 min 0.18 0.04 to 0.84
6–10 min 0.05 0.01 to 0.27
11–15 min 0.08 0.01 to 0.57
More than 15 min 0.11 0.02 to 0.71
Pre-registration and/or post-registration training in
adherence management and support
No 1.00
Yes 0.59 0.33 to 1.06
Use of practitioner guidelines to assist with management
of patient adherence to medication
No 1.00
Yes 0.82 0.42 to 1.58
*Intercept allowed to vary by country.
†Intercept allowed to vary by profession.
Table 3 Summary of multiple logistic regression for
asking patients about missed doses frequently or all the
time as the dependent variable
Variable OR 95% CI
Profession*
Doctor 1.00
Pharmacist 0.22 0.17 to 0.27
Nurse 1.12 0.90 to 1.41
Demographics†
Gender
Male 1.00
Female 1.02 0.84 to 1.23
Age
Per year 1.01 1.00 to 1.01
Professional practice†
Number of years registered as a qualified healthcare
professional
Less than 1 year 1.00
1–5 years 2.19 1.09 to 4.38
6–10 years 2.32 1.16 to 4.63
11–15 years 1.90 0.96 to 3.77
Over 15 years 2.08 1.08 to 4.00
Time spent talking with patients about their use of
medications
No time at all 1.00
Less than 1 min 3.69 0.72 to 18.95
1–5 min 3.88 0.80 to 18.89
6–10 min 6.12 1.25 to 29.95
11–15 min 8.40 1.67 to 42.31
More than 15 min 9.10 1.80 to 46.01
Pre-registration and/or post-registration training in
adherence management and support
No 1.00
Yes 1.42 1.16 to 1.74
Use of practitioner guidelines to assist with management
of patient adherence to medication
No 1.00
Yes 1.21 0.96 to 1.52
*Intercept allowed to vary by country.
†Intercept allowed to vary by profession.
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support adherence’ (α=0.72) showed good internal reli-
ability. The internal reliability of the measure for ‘assess-
ment of adherence and its risk factors’ fell marginally
below the accepted level of 0.70 (α=0.69). Results
derived from the total ratings for this section should,
therefore, be interpreted with caution.
Some categories of interventions were found to have a
high correlation with each other, using Pearson’s r with
a cut-off level of 0.5. Higher scores for frequency of use
of assessment interventions were found to correlate with
higher scores for the use of interventions focused on
talking with patients about their medications (r=0.53).
High scores for the use of interventions focused on
talking with patients about their medications were also
correlated with higher reported use of practical strat-
egies to make medication taking easier (r=0.58).
ANOVA: main effects
For the assessment of adherence and its correlates, a sig-
niﬁcant main effect was obtained for profession, F (2,
1678)=129.48, p<0.001. A Bonferroni multiple compari-
son test at the 5% level of signiﬁcance showed that all
three professional groups were signiﬁcantly different
from each other. Nurses reported signiﬁcantly greater
use of these interventions than doctors and pharmacists.
Doctors also reported signiﬁcantly greater use of these
interventions than pharmacists, p<0.05. There was also a
signiﬁcant main effect of nation on reported use of
interventions for the assessment of adherence and its
risk factors, F (9, 1678)=4.99, p<0.001. England, Portugal
and the Netherlands showed greater use of these inter-
ventions, and French healthcare professionals showed
the lowest use of assessment interventions.
For interventions focused on providing information
for patients or carers, there was a signiﬁcant main effect
of profession on healthcare professionals’ reported use,
F (2, 1990)=62.36, p<0.001. A Bonferroni multiple com-
parison test indicated that doctors reported signiﬁcantly
more frequent use of these interventions than nurses or
pharmacists, and nurses used these interventions signiﬁ-
cantly more often than pharmacists, p<0.05. A signiﬁcant
main effect of nation was also determined, F (9, 1990)
=14.06, p<0.001. Again, healthcare professionals in
England, the Netherlands and Portugal reported more
frequent use of these interventions. Austrian healthcare
professionals reported the lowest use of this category of
intervention.
The ANOVA conducted on the total use of interven-
tions regarding talking with patients about their medica-
tions revealed a signiﬁcant main effect of profession, F
(2, 547)=40.83, p<0.001. A Bonferroni multiple compari-
son test showed that nurses reported signiﬁcantly more
use of these interventions than doctors and pharmacists,
and doctors reported signiﬁcantly greater use than phar-
macists, p<0.05. There was also a signiﬁcant main effect
of nation, F (5, 547)=4.41, p<0.001. More use of these
interventions was reported by healthcare professionals in
Portugal and the Netherlands, and the least use was
reported by those in Belgium.
For healthcare professionals’ reported use of practical
strategies to make medication taking easier, a signiﬁcant
main effect of profession was determined, F (2, 1249)
=86.34, p<0.001. A Bonferroni multiple comparison test
showed that doctors reported signiﬁcantly greater use of
these interventions than nurses and pharmacists, and
nurses reported signiﬁcantly more use than pharmacists,
p<0.05. A signiﬁcant main effect of nation also emerged,
F (8, 1249)=7.19, p<0.001. Use of these interventions was
highest in England, the Netherlands and Portugal and
lowest in Austria and Switzerland.
For the ﬁnal category of interventions, focused on
involving others and other services to support adher-
ence, a signiﬁcant main effect of profession was found,
F (2, 1408)=63.85, p<0.001. A Bonferroni multiple com-
parison test revealed that nurses reported signiﬁcantly
greater use of these interventions than doctors and
pharmacists, p<0.05. Further, the mean total reported
use of these interventions by doctors was signiﬁcantly
higher than the mean total use by pharmacists, p<0.05.
A signiﬁcant main effect of nation was also observed for
this outcome, F (9, 1408)=26.55, p<0.001. Healthcare
professionals in Poland reported the highest use of
these interventions, and those in Austria, Germany and
Switzerland reported the least.
ANOVA: interaction effects
For the category of interventions pertaining to the
assessment of adherence and its risk factors, a signiﬁcant
main effect of profession was determined, F (2, 1445)
=8.98, p<0.01. There was, however, no signiﬁcant main
effect of nation, F (7, 1445)=.62, p>0.05. A signiﬁcant
interaction between profession and nation emerged, F
(14, 1445)=7.73, p<0.001. Pharmacists in England, the
Netherlands and Portugal reported more use of these
interventions than pharmacists from other countries.
Nurses in Austria and Switzerland reported less use of
these interventions than nurses in other countries.
There were no signiﬁcant main effects of profession, F
(2, 1689)=1.35, p>0.05, or nation, F (7, 1689)=1.30,
p>0.05, on healthcare professionals’ reported use of
interventions centred on the provision of information
for patients and carers. However, a signiﬁcant profession
x nation interaction was found, F (14, 1689)=8.83,
p<0.001. Nurses in England reported much higher, and
nurses in Austria much lower, use of these interventions
than nurses in other nations. Pharmacists in the
Netherlands and Portugal reported more frequent use
of these interventions, and pharmacists in Poland and
Switzerland less frequent use of these interventions.
For the use of interventions focused on talking with
patients about their medications, a signiﬁcant main
effect of profession was determined, F (2, 471)=7.80,
p<0.05. There was no signiﬁcant main effect of nation, F
(4, 471)=2.03, p>0.05. However, a signiﬁcant profession
x nation interaction effect was found, F (8, 471)=2.52,
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p<0.05. Nurses in the Netherlands reported higher use
of interventions in this category than nurses in other
countries. Pharmacists in Belgium and Switzerland
reported lower use of interventions in this category.
A similar pattern of ﬁndings was determined for
healthcare professionals’ use of practical strategies to
make medication taking easier. A signiﬁcant main effect
of profession was found, F (2, 1064)=10.50, p<0.01, but
there was no signiﬁcant main effect of nation, F (6,
1064)=1.42, p>0.05. A signiﬁcant interaction effect was
found, F (14, 1064)=4.18, p<0.001. Doctors in England,
the Netherlands and Switzerland reported lower use of
these interventions than doctors in other nations.
Nurses and pharmacists in England and the Netherlands
had higher use of interventions in this category than
nurses elsewhere.
For the ﬁnal category of interventions, focused on
involving others and other services to support adher-
ence, signiﬁcant main effects were found for profession,
F (2, 1201)=8.19, p<0.01, and for nation, F (7, 1201)
=6.95, p<0.01. Nurses reported signiﬁcantly greater use
of these interventions than doctors and pharmacists,
p<0.05. Healthcare professionals in Portugal and Poland
reported more frequent use of interventions than
healthcare professionals in other nations. A signiﬁcant
profession x nation interaction effect was also shown, F
(14, 1201)=3.44, p<0.001. Pharmacists in Poland
reported much lower use of these interventions than
Polish doctors and nurses who completed the survey.
DISCUSSION
Main findings
Healthcare professionals in Europe are limited in the
extent to which they intervene to assist patients having
long-term conditions with medication adherence.
Within intervention categories, mean total scores are
around or below the mid-point for ‘assessment of adher-
ence’, ‘practical strategies to make medication taking
easier’ and ‘involving others to support adherence’. The
categories ‘providing information for patients/carers’
and ‘talking with patients about their medications’ (of
which giving patients the opportunity to ask questions is
highly rated) both score slightly above the mid-point of
the total scale, suggesting these categories of interven-
tion are practised somewhat more frequently.
The analysis of the primary outcome, and of the
‘assessment of adherence’ category as a whole, generates
concern about the extent to which healthcare profes-
sionals seek to identify medication non-adherence in
routine clinical practice. Participants in the survey were
asked to answer each question only if the speciﬁc item
was relevant to their role. Thus participants for whom
the item was relevant to their role, and so answered the
question, could potentially have asked all patients about
missed doses of prescribed medication. In fact, about
half of the healthcare professionals in the survey ask
patients with long-term conditions whether they have
missed any doses of their medication on a regular basis,
a question identiﬁed as a key method for healthcare pro-
fessionals to assess adherence and so support patients
with medicines.12 However, the ﬁnding that healthcare
professionals who report that they have had some
element of training in medication adherence are more
likely to ask this key question, indicates that healthcare
professional behaviour may be amenable to change in
this regard.
Consistent differences were found in the extent to
which doctors, pharmacists and nurses report that they
manage and support patients with medication adher-
ence. For the primary outcome, and all ﬁve categories of
adherence intervention, pharmacists persistently report
that they intervene less than the other two professions to
support patients with medicines. In three instances of
ﬁve, nurses reported more intervention to assist patients
with prescribed medicines than doctors.
The differences between professions in the extent to
which they report that their day to day practice includes
supporting patients with long term conditions with med-
icines use is cause for concern. Within the primary care
team, pharmacists have particular expertise and training
in pharmaceuticals, yet this does not appear to translate
into a lead role in supporting patients with medicines
use within routine practice. It is possible that the phys-
ical environment and role of many pharmacists in com-
munity and primary care settings may hinder their
ability to assist patients to the same extent as nurses and
doctors. However, in this survey, pharmacists report no
less time spent talking with patients about their use of
medications than doctors, though both groups report
that they typically have less time than nurses do to spend
with individual patients. It is also unlikely that access to
training inhibited pharmacists from intervening to
support patients with medication adherence: pharma-
cists in this study reported receiving more adherence
training than either nurses or doctors. Future research
might usefully consider whether aspects of service provi-
sion, type and nature of training or healthcare culture
contribute to these differences in clinical behaviour.
No country effects were found for the primary
outcome examining responses to the question speciﬁc-
ally concerning whether healthcare professionals ask
patients if they have missed any doses of their medica-
tion. Differences between countries were found in the
extent to which healthcare professionals in primary care
settings intervene to support patients with medicines
use. Healthcare professionals in England, the
Netherlands and Portugal report more activity to
support patients with medicines use for three of the ﬁve
categories of intervention (‘assessment of adherence’,
‘providing information for patients/carers’ and ‘prac-
tical strategies to make medication taking easier’) than
healthcare professionals in the other countries.
Healthcare professionals in the Netherlands and
Portugal, but not England, also report more activity in
the ‘talking with patients about medications’ category.
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The pattern of ﬁndings is different for the ‘involving
others and other services to support adherence’ cat-
egory, for which Polish healthcare professionals report
more activity than healthcare professionals in other
countries. Interaction effects between profession and
countries are reported above for completeness but
should be interpreted with caution in the absence of a
main effect of country in the majority of these analyses.
The relatively small sample of healthcare professionals
in Portugal cautions against over-interpretation of ﬁnd-
ings for this nation. Results from England, the
Netherlands and Poland, however, are supported by
much larger samples.
A clear theme regarding the use of
adherence-enhancing interventions by healthcare profes-
sionals is the low reported use of technology and other
resources to support patients with medicines use in
routine practice. Resource-intensive approaches are uti-
lised less than resource-light approaches. Thus, blood or
urine screens and electronic monitoring to assess medica-
tion adherence, DVDs, video or computer resources for
information provision, and reminder systems such as text
messaging, mobile alarms, reminder charts and diaries,
are used less to support medication adherence than non-
technological, simple approaches, such as information
sharing and talking with patients about their medicines
use. Unfortunately, from this survey, we are unable to
determine whether this is due to the lack of availability of
such resources or a preference by healthcare profes-
sionals for less technologically-driven approaches.
However, we do know that healthcare professionals who
report use of these resource-intensive interventions, and
thus respond to the questions about perceived effective-
ness of the intervention items, are in general more likely
to report that they ‘don’t know’ how effective the inter-
ventions are than participants responding to other items.
Healthcare professionals in the study reported that, of
the interventions they use, provision of information to
patients and talking with patients about their medicines
use are more effective than other ways of intervening, in
their view. However, the sample does not strongly
endorse the effectiveness of many of the interventions
they use; only 10 of the 50 interventions have a modal
response of ‘extremely’ effective. It is possible then that
healthcare professionals struggle to get feedback on the
utility and effectiveness of their own actions towards sup-
porting patients with medication adherence. If so,
healthcare professionals may ﬁnd it difﬁcult to reﬂect
on, learn from and adapt their own practice to support
medicines use.
Strengths and limitations
In some countries, and for some professions, participant
recruitment, did not reach the target sample size.
Recruitment of general practitioners into the study was
a particular problem for some countries. In England,
for example, recruitment of pharmacists and nurses to
the study was steady and straightforward. Professional
bodies and regulators for general practitioners (GPs),
however, were less able to assist with recruitment. Two
countries, France and Germany, did not plan to collect
data for nurses working in a primary care setting.
Survey partners in those countries reported that the
study topic was not so relevant to the role of nurses in
those nations. For some analyses, the absence of a
nurse sample for all countries meant that interaction
effects could not be reported unless the whole data set
for those speciﬁc countries was excluded.
The study focused on the behaviours of healthcare
professionals working in a primary care setting. This
study does not tell us about behaviours to support medi-
cation adherence by those working in secondary care
health services, nor is it possible to determine the extent
to which the results of the present study may be general-
isable to other settings. The survey concerns self-report
by healthcare professionals of the interventions they
undertake towards managing and supporting patients
with medication adherence. We have no objective evi-
dence to support these self-reports. Equally, we have no
information about the patient experience of support
with medicines taking by the professionals participating
in the study. Furthermore, healthcare professionals com-
pleting this survey chose whether to participate or not.
This self-selected sample may be more interested in
medicines and medicines use than the healthcare pro-
fessional population at large. If so, this study may over-
estimate the proportion of healthcare professionals who
use adherence-enhancing interventions.
To our knowledge, however, this study is the largest
survey of European healthcare professionals’ behaviour
towards supporting patients with medication adher-
ence. Keeping in mind the caveats above, the results
add to our understanding of how frequently healthcare
professionals intervene to support patients with medi-
cines use in everyday practice, and their perceptions of
the efﬁcacy of that intervention. The international
nature of this study enables analysis of variability
observed in healthcare professionals’ beliefs and beha-
viours across 10 European nations. This may provide a
basis within each country for promoting routine and
continuous efforts, to educate and modify the behav-
iour of healthcare professionals in order to enable
them to fulﬁl their roles in supporting patients with
medicine taking.
Implications for clinicians and policymakers
Our study shows that there is plenty of scope for primary
care healthcare professionals to increase the frequency
with which they provide support to patients with long-
term conditions who are prescribed medication.
This study provides evidence to support a strong case
for educators to reﬂect on the nature and extent of the
education and training provided to healthcare profes-
sionals, for managing and supporting patients with
medication adherence. Our educational framework,
based in part on this survey,13 which includes a
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competency framework, learning outcomes and an
assessment tool, may form a basis for education for pre-
registration training and for continuing professional
development for healthcare professionals.
We recommend that a quality standard for medication
adherence support for people with long-term conditions
should be implemented in primary care settings in
Europe, based on the following quality statement:
people prescribed medication(s) for long-term condi-
tions receive an assessment that identiﬁes the extent of
their non-adherence to medication. The recommended
quality measure is the proportion of patients prescribed
medication who are asked whether they have missed any
doses of their medication for a recent timeframe during
their most recent consultation (numerator—the number
of people with a long-term condition prescribed medica-
tion who were asked whether they have missed any doses
of their medication during their most recent consult-
ation; denominator—the number of all patients with a
long-term condition prescribed medication). The aim of
this quality standard is to make medication adherence
assessment a regular and routine part of primary health-
care, and so provide a basis for healthcare professionals
to support patients reporting non-adherence with medi-
cines use when necessary.
Unanswered questions and future research
Further study is needed to investigate ways in which
healthcare professionals can receive feedback about
the impact and effectiveness of speciﬁc adherence-
enhancing interventions used in routine clinical
practice, to support them in reﬂecting on and improving
their practice. Previous studies of clinical behaviour
change for other aspects of clinical practice have used
social cognitive theory to understand the determinants
of healthcare professional behaviour and as the basis for
the design of interventions to change the clinical prac-
tice of healthcare professionals.14–16 Future research
might adopt the same approach in the development of
interventions improve the uptake of medication adher-
ence guidelines by healthcare professionals.
We have also identiﬁed a discrepancy between the
nature of medicines adherence support provided in
routine clinical practice and the nature of the often
complex adherence-enhancing interventions reported in
intervention studies.3 The implementation of trial-based
interventions into routine clinical practice is likely, there-
fore, to need careful consideration.
CONCLUSION
Healthcare professionals in Europe are limited in the
extent to which they intervene to assist patients with
long-term conditions with medication adherence. This
represents a missed opportunity to support people with
prescribed treatment.
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